Prostate Cancer Clinical Trials in Tampa, FL

Prostate Cancer Clinical Trials in Tampa, FL

View the best 10 prostate cancer medical studies in Tampa, Florida. Access promising new therapies by applying to a Tampa-based Prostate Cancer clinical trial.

Trials in Tampa, Florida

Here are the top 10 medical studies for prostate cancer in Tampa, Florida

Image of Moffitt Caner Center in Tampa, United States.

Docetaxel

Anti-tumor antibiotic

Recruiting1 awardPhase 2
This trial aims to see if using a combination of adaptive androgen deprivation therapy (ADT) and Docetaxel can help in extending the period of time before prostate cancer becomes resistant to treatment.
Image of The Stamford Hospital in Stamford, United States.

Relugolix

Gonadotropin-Releasing Hormone (GnRH) Antagonist

Recruiting1 award
"This trial aims to gather real-world information on how safe and effective ORGOVYX is for patients with prostate cancer in regular clinical settings. It will also look at how patients respond to treatment with
Image of Moffitt Cancer Center in Tampa, United States.

MSGV1-PSCA-8T28Z

CAR T-cell Therapy

Recruiting1 awardPhase 1
This trial is for patients with advanced prostate cancer that has spread to other parts of the body. The trial will test a new treatment using modified immune cells to target the cancer cells. The goal is to
Image of Tower Urology in Los Angeles, United States.

Copper Cu 64 PSMA I&T

Cancer Imaging Agent

Recruiting2 awardsPhase 3
This trial will test a new imaging technique using copper Cu 64 PSMA I&T injection in patients with newly diagnosed aggressive prostate cancer to see if it can help doctors better visualize the extent of the cancer
Image of Research Site in Tucson, United States.

Placebo +1 More

Hormone Therapy

Recruiting1 awardPhase 3
This trial is testing a new drug called Saruparib combined with hormone treatment in adults with prostate cancer that has spread but still responds to hormones. The drug aims to stop cancer cells from repairing themselves, potentially slowing down the disease.
Image of Clinical Trial Site in La Jolla, United States.

ARV-766

Androgen Receptor Antagonist

Recruiting1 awardPhase 1 & 2
This trial is testing a new oral drug called ARV-766, alone or with abiraterone, in men with advanced prostate cancer that has spread. The drug works by blocking proteins that help cancer cells grow. Abiraterone is a well-established drug used in the treatment of metastatic castration-resistant prostate cancer, often in combination with other therapies.
Image of VA Long Beach Healthcare System, Long Beach, CA in Long Beach, United States.

Relugolix +11 More

Hormone Therapy

Recruiting1 awardPhase 2 & 3
This trial is testing whether adding PET-directed local therapy to standard systemic therapy improves disease control in Veterans with oligorecurrent prostate cancer.
Image of Urology Centers Of Alabama in Homewood, United States.

Niraparib +2 More

PARP Inhibitor

Recruiting1 awardPhase 3
This trial will compare the effect of adding niraparib to abiraterone acetate plus prednisone, versus abiraterone acetate plus prednisone and placebo, in men with metastatic castration-resistant prostate cancer.
Image of NCT02257736 in Phoenix, United States.

Prednisone +2 More

Corticosteroid

Recruiting1 awardPhase 3
This trial tests apalutamide added to a standard treatment for advanced prostate cancer. It targets patients whose cancer has spread and who haven't had chemotherapy. The treatment works by blocking and lowering male hormones that help cancer grow. Apalutamide has shown efficacy in treating different stages of prostate cancer.
Image of Mobile Infirmary Medical Center in Mobile, United States.

External Beam Radiation Therapy +3 More

Radiation

Recruiting1 awardPhase 2 & 3
This trial is testing docetaxel in combination with antiandrogen therapy and radiation therapy versus antiandrogen therapy and radiation therapy alone in treating patients with prostate cancer that has been removed by surgery.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.